GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vertex Pharmaceuticals Inc (MIL:1VRTX) » Definitions » Other Gross PPE

Vertex Pharmaceuticals (MIL:1VRTX) Other Gross PPE : €2,265 Mil (As of Sep. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Vertex Pharmaceuticals Other Gross PPE?

Vertex Pharmaceuticals's Other Gross PPE for the quarter that ended in Sep. 2024 was €2,265 Mil.

Vertex Pharmaceuticals's quarterly Other Gross PPE increased from Mar. 2024 (€1,367 Mil) to Jun. 2024 (€1,645 Mil) and increased from Jun. 2024 (€1,645 Mil) to Sep. 2024 (€2,265 Mil).

Vertex Pharmaceuticals's annual Other Gross PPE increased from Dec. 2021 (€614 Mil) to Dec. 2022 (€716 Mil) but then declined from Dec. 2022 (€716 Mil) to Dec. 2023 (€704 Mil).


Vertex Pharmaceuticals Other Gross PPE Historical Data

The historical data trend for Vertex Pharmaceuticals's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vertex Pharmaceuticals Other Gross PPE Chart

Vertex Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Gross PPE
Get a 7-Day Free Trial Premium Member Only Premium Member Only 237.57 460.48 614.01 715.84 704.44

Vertex Pharmaceuticals Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,344.13 704.44 1,366.84 1,644.98 2,265.02

Vertex Pharmaceuticals Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


Vertex Pharmaceuticals Business Description

Address
50 Northern Avenue, Boston, MA, USA, 02210
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex has diversified its portfolio through Casgevy, a gene-editing therapy for beta thalassemia and sickle-cell disease. Additionally, Vertex is evaluating small-molecule inhibitors targeting acute and chronic pain using nonopioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.

Vertex Pharmaceuticals Headlines

No Headlines